Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central serous chorioretinopathy: An evidence-based treatment guideline.
Feenstra HMA, van Dijk EHC, Cheung CMG, Ohno-Matsui K, Lai TYY, Koizumi H, Larsen M, Querques G, Downes SM, Yzer S, Breazzano MP, Subhi Y, Tadayoni R, Priglinger SG, Pauleikhoff LJB, Lange CAK, Loewenstein A, Diederen RMH, Schlingemann RO, Hoyng CB, Chhablani JK, Holz FG, Sivaprasad S, Lotery AJ, Yannuzzi LA, Freund KB, Boon CJF. Feenstra HMA, et al. Prog Retin Eye Res. 2024 Jul;101:101236. doi: 10.1016/j.preteyeres.2024.101236. Epub 2024 Feb 1. Prog Retin Eye Res. 2024. PMID: 38301969 Free article. Review.
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial.
van Rijssen TJ, van Dijk EHC, Tsonaka R, Feenstra HMA, Dijkman G, Peters PJH, Diederen RMH, Hoyng CB, Schlingemann RO, Boon CJF. van Rijssen TJ, et al. Among authors: feenstra hma. Am J Ophthalmol. 2022 Jan;233:101-110. doi: 10.1016/j.ajo.2021.06.020. Epub 2021 Jun 29. Am J Ophthalmol. 2022. PMID: 34214454 Clinical Trial.
EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Feenstra HMA, Hahn LC, van Rijssen TJ, Tsonaka R, Breukink MB, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Fauser S, Hoyng CB, van Dijk EHC, Boon CJF. Feenstra HMA, et al. Retina. 2022 Apr 1;42(4):721-729. doi: 10.1097/IAE.0000000000003363. Retina. 2022. PMID: 34864802 Clinical Trial.
Spontaneous Resolution of Chronic Central Serous Chorioretinopathy: "Fuji Sign".
Feenstra HMA, Hensman J, Gkika T, Lipkova V, Hoyng CB, Diederen RMH, Schlingemann RO, Downes SM, van Dijk EHC, Boon CJF. Feenstra HMA, et al. Ophthalmol Retina. 2022 Sep;6(9):861-863. doi: 10.1016/j.oret.2022.04.023. Epub 2022 May 6. Ophthalmol Retina. 2022. PMID: 35533974 Free article. No abstract available.
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.
Feenstra HMA, van Dijk EHC, van Rijssen TJ, Tsonaka R, Diederen RMH, Hoyng CB, Schlingemann RO, Boon CJF. Feenstra HMA, et al. Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):659-668. doi: 10.1007/s00417-022-05836-x. Epub 2022 Oct 7. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36202933 Free PMC article. Clinical Trial.
Argon laser photocoagulation in polypoidal choroidal vasculopathy.
Sirks MJ, Feenstra HMA, de Vries FR, Dijkman G, Boon CJF, van Dijk EHC. Sirks MJ, et al. Among authors: feenstra hma. Clin Exp Ophthalmol. 2023 Mar;51(2):177-179. doi: 10.1111/ceo.14191. Epub 2022 Nov 23. Clin Exp Ophthalmol. 2023. PMID: 36398567 No abstract available.
15 results